Daniel Patrick McGuire - 04 Jun 2026 Form 3 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Reporting relationship: SVP, GC and Secretary
Issuer ticker: VNDA
Reported as of: 04 Jun 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 08 Jun 2026, 16:12:28 UTC
Source filing: View source filing
Reporting owner signature: /s/ Daniel McGuire

Key filing fact

Daniel Patrick McGuire filed Form 3 for Vanda Pharmaceuticals Inc. (VNDA) on 08 Jun 2026.

Key facts

This page summarizes Daniel Patrick McGuire's Form 3 filing for Vanda Pharmaceuticals Inc. (VNDA).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Jun 2026, 16:12.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002138590 Primary reporting owner

McGuire Daniel Patrick

Relationship: SVP, GC and Secretary
Address: 2200 PENNSYLVANIA AVE. NW, SUITE 300E, WASHINGTON
Signature: /s/ Daniel McGuire
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,732
Date: 04 Jun 2026
Ownership: Direct

VNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,000
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F1

VNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,250
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F2

VNDA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,000
Date: 04 Jun 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares of common stock underlying an RSU award. One-third of the RSU will vest on July 29, 2026, 1/3 will vest on July 29, 2027, and the remaining 1/3 will vest on July 29, 2028, provided the Reporting Person remains continuously employed by the Issuer through each vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.

Footnote F2

Represents shares of common stock underlying an RSU award. The RSU vests as follows: 1/3 will vest on March 1, 2027, 1/3 will vest on March 1, 2028, and the remaining 1/3 will vest on March 1, 2029, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.

Footnote F3

Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.